78 related articles for article (PubMed ID: 21277347)
61. Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
[No Abstract] [Full Text] [Related]
62. The growth factor independence-1 (Gfi1) is overexpressed in chronic myelogenous leukemia.
Huang M; Hu Z; Chang W; Ou D; Zhou J; Zhang Y
Acta Haematol; 2010; 123(1):1-5. PubMed ID: 19887785
[TBL] [Abstract][Full Text] [Related]
63. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia.
Kabarowski JH; Witte ON
Stem Cells; 2000; 18(6):399-408. PubMed ID: 11072027
[TBL] [Abstract][Full Text] [Related]
64. Therapy-related acute leukemia.
Karp JE; Sarkodee-Adoo CB
Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
[TBL] [Abstract][Full Text] [Related]
65. [Leukemias and malignant lymphomas in children].
Schmiegelow K
Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
[No Abstract] [Full Text] [Related]
66. [Properties of leukemic stem cells and treatment strategy for the cure of chronic myelogenous leukemia].
Minami Y
Rinsho Ketsueki; 2013 Jun; 54(6):552-8. PubMed ID: 23823094
[No Abstract] [Full Text] [Related]
67. [Gene therapy and regenerative medicine for metabolic syndrome].
Sonoyama T; Sone M; Nakao K
Nihon Rinsho; 2011 Jan; 69 Suppl 1():716-20. PubMed ID: 21766687
[No Abstract] [Full Text] [Related]
68. Exciting times for our field and the Journal.
Humphries RK
Exp Hematol; 2011 Mar; 39(3):271. PubMed ID: 21277347
[No Abstract] [Full Text] [Related]
69. [Pathophysiology and treatment of acute myeloid leukemia].
Naoe J
Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
[No Abstract] [Full Text] [Related]
70. [Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons].
Cazzola M; Pedrazzoli P; Bergamaschi G; Buonanno C; Cuomo A; D'Uva R; Ponchio L; Rosti V; Zappone E; Ascari E
Haematologica; 1990; 75 Suppl 4():20-7. PubMed ID: 2127411
[No Abstract] [Full Text] [Related]
71. Autologous blood stem cell transplantation.
Goldman JM
Beitr Infusionsther; 1988; 21():317-21. PubMed ID: 2463002
[No Abstract] [Full Text] [Related]
72. [Chronic myeloid leukemia as a model for the development and therapeutic use of tyrosine kinase inhibitors].
López-Karpovitch X
Rev Invest Clin; 2003; 55(2):191-5. PubMed ID: 12827926
[No Abstract] [Full Text] [Related]
73. Recent advancements in the treatment of chronic myelogenous leukemia.
O'Dwyer ME; Mauro MJ; Druker BJ
Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]